Genetics of QT Response to Moxifloxacin
NCT01936480
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
51
Enrollment
OTHER
Sponsor class
Stopped
Recruitment difficulties
Conditions
Cardiac Arrhythmias
Interventions
DRUG:
Moxifloxacin 400mg once time
Sponsor
Massachusetts General Hospital